Long-Term Liabilities: The sum of all non-current liabilities.
Apogee Therapeutics Inc. (APGE) had Long-Term Liabilities of $103.70M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-85.85M |
|
-- |
|
-- |
|
$96.00M |
|
$-96.00M |
|
$10.23M |
|
$-85.78M |
|
$-85.78M |
|
$-85.85M |
|
$-85.85M |
|
$-85.85M |
|
$-85.85M |
|
$-96.00M |
|
$-97.34M |
|
75.44M |
|
75.44M |
|
$-1.14 |
|
$-1.14 |
|
| Balance Sheet Financials | |
$991.73M |
|
$4.82M |
|
$344.08M |
|
$1.34B |
|
$37.51M |
|
-- |
|
|
Long-Term Liabilities |
$103.70M |
$141.21M |
|
$1.19B |
|
$1.19B |
|
$1.19B |
|
75.34M |
|
| Cash Flow Statement Financials | |
$-126.95M |
|
$-417.21M |
|
$518.18M |
|
$131.55M |
|
$105.57M |
|
$-25.98M |
|
$33.82M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
26.44 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-126.94M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-7.19% |
|
-7.19% |
|
-6.43% |
|
-7.19% |
|
$15.86 |
|
$-1.68 |
|
$-1.68 |
|